These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

51 related articles for article (PubMed ID: 32422133)

  • 1. Methyl-CpG-binding domain 3 inhibits stemness of pancreatic cancer cells via Hippo signaling.
    Wang H; Feng W; Chen W; He J; Min J; Liu Y; Li F; Chen J; Wu S; Chen B; Gong A; Xu M
    Exp Cell Res; 2020 Aug; 393(1):112091. PubMed ID: 32422133
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Platelet‑derived growth factor‑BB mediates pancreatic cancer malignancy via regulation of the Hippo/Yes‑associated protein signaling pathway.
    Li T; Guo T; Liu H; Jiang H; Wang Y
    Oncol Rep; 2021 Jan; 45(1):83-94. PubMed ID: 33416116
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Linc-RoR promotes proliferation, migration, and invasion via the Hippo/YAP pathway in pancreatic cancer cells.
    Chen W; Wang H; Liu Y; Xu W; Ling C; Li Y; Liu J; Chen M; Zhang Y; Chen B; Gong A; Xu M
    J Cell Biochem; 2020 Jan; 121(1):632-641. PubMed ID: 31452251
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Furin promotes epithelial-mesenchymal transition in pancreatic cancer cells via Hippo-YAP pathway.
    Zhang Y; Zhou M; Wei H; Zhou H; He J; Lu Y; Wang D; Chen B; Zeng J; Peng W; Du F; Gong A; Xu M
    Int J Oncol; 2017 Apr; 50(4):1352-1362. PubMed ID: 28259973
    [TBL] [Abstract][Full Text] [Related]  

  • 5. LncRNA UCA1 promotes migration and invasion in pancreatic cancer cells via the Hippo pathway.
    Zhang M; Zhao Y; Zhang Y; Wang D; Gu S; Feng W; Peng W; Gong A; Xu M
    Biochim Biophys Acta Mol Basis Dis; 2018 May; 1864(5 Pt A):1770-1782. PubMed ID: 29510195
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Methyl-CpG-binding domain 3 inhibits epithelial-mesenchymal transition in pancreatic cancer cells via TGF-β/Smad signalling.
    Xu M; He J; Li J; Feng W; Zhou H; Wei H; Zhou M; Lu Y; Zeng J; Peng W; Du F; Gong A
    Br J Cancer; 2017 Jan; 116(1):91-99. PubMed ID: 27898661
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Stiehopus japonieus acidic mucopolysaccharide inhibits the proliferation of pancreatic cancer SW1990 cells through Hippo-YAP pathway.
    Li X; Liu Y; Zhang C; Niu Q; Wang H; Che C; Xie M; Zhou B; Xu Y; Zhang Q; Wu J; Tian Z
    Oncotarget; 2017 Mar; 8(10):16356-16366. PubMed ID: 28099921
    [TBL] [Abstract][Full Text] [Related]  

  • 8. TNFAIP8 regulates Hippo pathway through interacting with LATS1 to promote cell proliferation and invasion in lung cancer.
    Han Y; Tang Z; Zhao Y; Li Q; Wang E
    Mol Carcinog; 2018 Feb; 57(2):159-166. PubMed ID: 28926138
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chinese Propolis Suppressed Pancreatic Cancer Panc-1 Cells Proliferation and Migration via Hippo-YAP Pathway.
    Tao L; Chen X; Zheng Y; Wu Y; Jiang X; You M; Li S; Hu F
    Molecules; 2021 May; 26(9):. PubMed ID: 34068565
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MeCP2 suppresses LIN28A expression via binding to its methylated-CpG islands in pancreatic cancer cells.
    Xu M; Bian S; Li J; He J; Chen H; Ge L; Jiao Z; Zhang Y; Peng W; Du F; Mo Y; Gong A
    Oncotarget; 2016 Mar; 7(12):14476-85. PubMed ID: 26910839
    [TBL] [Abstract][Full Text] [Related]  

  • 11. SOX2 maintains the stemness of retinoblastoma stem-like cells through Hippo/YAP signaling pathway.
    Zhao N; Zhou L; Lu Q; Wang S; Sun Y; Ding Y; Liu M; He H; Lang T
    Exp Eye Res; 2022 Jan; 214():108887. PubMed ID: 34890603
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lysine demethylase 2 (KDM2B) regulates hippo pathway via MOB1 to promote pancreatic ductal adenocarcinoma (PDAC) progression.
    Quan M; Chen Z; Jiao F; Xiao X; Xia Q; Chen J; Chao Q; Li Y; Gao Y; Yang H; Wang L; Cui J
    J Exp Clin Cancer Res; 2020 Jan; 39(1):13. PubMed ID: 31941533
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of titanium ions on the Hippo/YAP signaling pathway in regulating biological behaviors of MC3T3-E1 osteoblasts.
    Zhu WQ; Ming PP; Qiu J; Shao SY; Yu YJ; Chen JX; Yang J; Xu LN; Zhang SM; Tang CB
    J Appl Toxicol; 2018 Jun; 38(6):824-833. PubMed ID: 29377205
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The therapeutic targeting of the FGFR1/Src/NF-κB signaling axis inhibits pancreatic ductal adenocarcinoma stemness and oncogenicity.
    Lai SW; Bamodu OA; Tsai WC; Chang YM; Lee WH; Yeh CT; Chao TY
    Clin Exp Metastasis; 2018 Oct; 35(7):663-677. PubMed ID: 29987671
    [TBL] [Abstract][Full Text] [Related]  

  • 15. PTPRU, As A Tumor Suppressor, Inhibits Cancer Stemness By Attenuating Hippo/YAP Signaling Pathway.
    Gu J; Zhang Z; Lang T; Ma X; Yang L; Xu J; Tian C; Han K; Qiu J
    Onco Targets Ther; 2019; 12():8095-8104. PubMed ID: 31632062
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hippo/YAP Pathway Plays a Critical Role in Effect of GDNF Against Aβ-Induced Inflammation in Microglial Cells.
    Qing J; Liu X; Wu Q; Zhou M; Zhang Y; Mazhar M; Huang X; Wang L; He F
    DNA Cell Biol; 2020 Jun; 39(6):1064-1071. PubMed ID: 32255663
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Acetylation of VGLL4 Regulates Hippo-YAP Signaling and Postnatal Cardiac Growth.
    Lin Z; Guo H; Cao Y; Zohrabian S; Zhou P; Ma Q; VanDusen N; Guo Y; Zhang J; Stevens SM; Liang F; Quan Q; van Gorp PR; Li A; Dos Remedios C; He A; Bezzerides VJ; Pu WT
    Dev Cell; 2016 Nov; 39(4):466-479. PubMed ID: 27720608
    [TBL] [Abstract][Full Text] [Related]  

  • 18. YAP/TAZ enhance mammalian embryonic neural stem cell characteristics in a Tead-dependent manner.
    Han D; Byun SH; Park S; Kim J; Kim I; Ha S; Kwon M; Yoon K
    Biochem Biophys Res Commun; 2015 Feb; 458(1):110-6. PubMed ID: 25634692
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Phosphodiesterase 5/protein kinase G signal governs stemness of prostate cancer stem cells through Hippo pathway.
    Liu N; Mei L; Fan X; Tang C; Ji X; Hu X; Shi W; Qian Y; Hussain M; Wu J; Wang C; Lin S; Wu X
    Cancer Lett; 2016 Aug; 378(1):38-50. PubMed ID: 27179930
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Methyl-CpG binding domain protein 3: a new diagnostic marker and potential therapeutic target of melanoma.
    Ishibashi T; Kajihara I; Mizuhashi S; Kuriyama H; Kimura T; Kanemaru H; Makino K; Miyashita A; Aoi J; Makino T; Fukushima S; Kita K; Ihn H
    Biosci Trends; 2020 Nov; 14(5):390-395. PubMed ID: 32963182
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.